CEO Sam Altman and several OpenAI executives stepped into a "food fight" over Anthropic's Super Bowl ad and threw jabs at ...
Brain imaging technologies (e.g., MRI, PET, advanced microscopy) are foundational tools for deciphering the brain's ...
In this episode of Lexicon, we sit down with Aya Durbin, Director of Product ...
The future of the former Harmar Elementary School property is being discussed in Marietta, and after a year‑long community ...
Shareholder/Analyst Call February 5, 2026 3:30 PM ESTCompany ParticipantsRyan Watts - Co-Founder, President, CEO ...
POCATELLO — Idaho State University is laying off 45 people and enacting significant structural changes impacting four colleges as it works to address an $8 million deficit caused by a ...
A trial found that off-the-shelf TRX103 Tr1 cells were safe to use after mismatched donor stem cell transplant, showing engraftment and dose-dependent expansion and persistence.
Designed to reinforce lucerastat as the first oral therapy suitable for all patients with Fabry disease, irrespective of their mutation type. The program is expected to support a potential regulatory ...